Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.
By S. Petersen, Lai Wang, Asligul Yalcin-Chin, Lin Li, M. Peyton, J. Minna, P. Harran, Xiaodong Wang. Cancer Cell, 2007
606 citations recorded by the source corpus.
Subfields: Cancer Research, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/05d57aba25b455589dc450c48d921bffd416e9b9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Immunology
In Molecular Biology
Citations in the corpus
- Life and death by death receptors (2009, background): “Furthermore, in the absence of c-IAP1/2 (cellular inhibitor of apoptosis 1/2), death receptors such as TNF-R1 (vide infra) can signal cell death despite NF- B activation (110).”
- Targeting IAP proteins for therapeutic intervention in cancer (2012, background): “However, the most striking feature of bivalent antagonists is their high potency in cell death assays and tumour growth inhibition assay”
- cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. (2008, result): “This work complements and extends data from several recent papers published after the submission of this manuscript (Gaither et al., 2007; Petersen et al., 2007; Varfolomeev et al., 2007; Vince et al., 2007).”
- Ubiquitylation in innate and adaptive immunity (2009, background): “The binding of SMAC, or small-molecule SMAC mimetics, to cIAPs induces the dimerization, autoubiquitylation and proteasomal degradation of these ubiquitin ligase”
- The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. (2011, background): “…cells die upon cIAP depletion because loss of cIAPs results in enhanced sensitivity to autocrine TNF. ‘‘SM-resistant’’ cells stay alive because they do not produce TNF (Cheung et al., 2009; Petersen et al., 2007). cIAP depletion also occurs in response to genotoxic stress (Yang et al., 2000).”
- Tumour necrosis factor and cancer (2009, background): “SMAC (also known as DIABLO) mimetic drugs switch off the survival and inflammatory pathways that are normally induced by autocrine TNF ( Box 2 ), causing those cancer cell lines that produce TNF to self-destruc”
- Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. (2009, background): “A Smac Mimetic Plus a Pan-Caspase Inhibitor Induce Necrosis in HT-29 Cells Smac mimetics have been shown to induce apoptosis in certain tumor cell lines (Petersen et al., 2007; Vince et al., 2007; Varfolomeev et al., 2007), and death can be completely blocked with a pan-caspase inhibitor, z-VAD.”